Abbott gets an option to acquire Advanced Cardiac Therapeutics
Paired with announcements regarding the acquisition of Topera Medical Inc. and a minority investment in VytronUS, Abbott Laboratories Inc. continues on its quest to make a strong entry into the electrophysiology market through also gaining the option to acquire Advanced Cardiac Therapeutics Inc. (ACT), a privately owned firm developing a new cardiac ablation catheter.
- Medical Devices
- Full Acquisition
Please contact Sales at: (212) 520-2765 or email [email protected]
All set! This article has been sent to email@example.com.
All fields are required. For multiple recipients, separate email addresses with a semicolon.